Keyphrases
Acute Ischemic Stroke
100%
Cerebral Amyloid Angiopathy
44%
Intracerebral Hemorrhage
29%
Older Adults
26%
Tissue Plasminogen Activator (t-PA)
22%
Confidence Interval
22%
Recombinant Tissue Plasminogen Activator (rt-PA)
19%
White Matter Hyperintensities
18%
Discharge Outcomes
17%
Ischemic Stroke
16%
Alzheimer's Disease
16%
Diffusion-weighted Imaging
15%
Ambulance
15%
Small Vessel Disease
15%
Image Features
15%
Retrograde Amnesia
14%
Advanced Imaging
14%
Reperfusion
13%
Hemorrhagic Transformation
12%
Modified Rankin Scale
12%
Odds Ratio
11%
Endovascular Therapy
11%
Mechanical Thrombectomy
11%
Diffusion Magnetic Resonance Imaging (dMRI)
10%
Recanalization
10%
Stroke Outcome
9%
Reperfusion Therapy
9%
Neurological Improvement
8%
Thrombectomy
8%
Age Differences
8%
Clinical Trials
8%
Emergency Department
8%
Symptom Onset
8%
Hypertension
8%
Clinical Features
8%
National Institutes of Health Stroke Scale (NIHSS)
8%
Periventricular
7%
United States
7%
Non-traumatic
7%
Magnetic Resonance Imaging
7%
Everolimus
7%
Distributed Databases
7%
Tissue-based
7%
Celecoxib
7%
Acute Ischemic
7%
Diagnostic Accuracy
7%
Hospital Characteristics
7%
Sentinel
7%
Silent Stroke
7%
Self-harm
7%
Medicine and Dentistry
Apoplexy
98%
Brain Ischemia
83%
Alteplase
34%
Vascular Amyloidosis
32%
Cerebral Hemorrhage
28%
National Institutes of Health Stroke Scale
21%
Odds Ratio
20%
Magnetic Resonance Imaging
17%
Diffusion MRI
16%
Small Vessel Disease
16%
Systematic Review
16%
Prevalence
14%
Modified Rankin Scale
12%
Endovascular Surgery
12%
Recanalization
10%
Thrombectomy
9%
Triage
8%
Infarction
8%
Blood Clot Lysis
7%
Multivariate Analysis
7%
Everolimus
7%
Carotid Artery Stenosis
7%
Retina Ischemia
7%
Embolic Stroke
7%
ICD-9-CM
7%
Diagnosis Code
7%
Patient with Alzheimer's Disease
7%
Cranial Neuropathy
7%
Meta-Analysis
7%
Blood Pressure
7%
Carotid Artery Stenting
7%
Bilirubin
7%
Reperfusion Therapy
7%
Neurology
7%
Physiotherapy
7%
Cyclosporine
7%
Cerebral Venous Sinus Thrombosis
7%
Patient-Data
7%
Rapamycin
7%
Racial Disparity
7%
Left Ventricular Hypertrophy
7%
Nervous System Disorder
7%
Tacrolimus
7%
Stroke Therapy
7%
Tissue Plasminogen Activator
6%
Hazard Ratio
5%
Clinical Trial
5%
Infusion
5%
Flight
5%
Central Retinal Artery Occlusion
5%